Ansa Biotechnologies, Inc. filed a Form D with the SEC, reporting $54.4M sold, of a $71.9M offering.
What happened
Ansa Biotechnologies, Inc. is a corporation based in Emeryville, California, and filed a Form D for a cash raise with a total offering amount of $71,903,290. The filing reports $54,403,290 sold to 18 investors and lists Jason Gammack and Daniel Lin-Arlow as executive officers/directors, with Yanniv Dorone, Brad Crutchfield, and Nate Cornell as directors.
Source
Extracted by Autobound
From the Signal API record- Signal
- Form D offering
What this signalsNew funding often brings new budget and vendor reviews.
- Amount
- $54.4M
- Location
- EMERYVILLE, CALIFORNIA
- Filed
- Nov 18, 2026
- Jurisdiction
- Delaware
- Business location
- Emeryville, CA
More form D offering signals at other companies
- Form D offeringGalvanize Therapeutics, Inc.Galvanize Therapeutics, Inc. filed a Form D with the SEC, reporting $136.2M sold, of a $136.2M offering.Form D offering
- Form D offeringRising Tide Dental Holdings, LLCRising Tide Dental Holdings, LLC filed a Form D with the SEC, reporting $61.7M sold, of a $61.7M offering.Form D offering
- Form D offeringNexus Networks, Inc.Nexus Networks, Inc. filed a Form D with the SEC, reporting $47.1M sold, of a $47.5M offering.Form D offering
The full record
From the Signal API recordPeople
- Jason GammackExecutive Officer, Director · Named in the filing
- Daniel Lin-ArlowExecutive Officer, Director · Named in the filing
- Yanniv DoroneDirector · Named in the filing
- Brad CrutchfieldDirector · Named in the filing
- Nate CornellDirector · Named in the filing
- Nick NaclerioDirector · Named in the filing
- Chenny ZhangDirector · Named in the filing
- Matthias ArenskotterExecutive Officer · Named in the filing
Numbers
- Amount (USD)
- $54.4M
- Investors
- 18
- Remaining (USD)
- $17.5M
- Offering size (USD)
- $71.9M
Details
- CIK
- 0001816722
- Website
- ansabio.com
- Form
- D
- Entity type
- Corporation
- Primary topic
- Biotechnology
- Revenue range
- Decline to Disclose
- Business state
- CA
- Accession number
- 0001231919-26-001596
- Resolved entity type
- Operating company
- Has non accredited investors
- No
Topics and mentions
Topics
- Private Placement
- Biotechnology
- Corporation
Exemptions
- 06b
Securities
- Equity
Extraction
- Confidence
- High
- Relevance
- 60%
- Detected
- Nov 18, 2026
- signal_type
sec-form-d-funding- signal_subtype
newFilingCompany
Use this data
Get every form D offering signal for Ansa Biotechnologies, Inc. and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Ansa Biotechnologies, Inc. this week?”
Send it to your own tools
The Signal API returns form D offering signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-form-d-funding record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/fd-0001231919-26-001596 returns this record as JSON. POST /v1/companies/enrich returns every signal for ansabio.com.
{
"signal_id": "fd-0001231919-26-001596",
"signal_type": "sec-form-d-funding",
"signal_subtype": "newFilingCompany",
"detected_at": "2026-11-18T00:00:00+00:00",
"company": {
"name": "Ansa Biotechnologies, Inc.",
"domain": "ansabio.com"
},
"data": {
"cik": "0001816722",
"phone": "9256908100",
"detail": "The filing indicates a private securities offering by a biotechnology company, but it does not provide operating details beyond the disclosed entity type, location, and key personnel. With no website resolved, the company’s business activities should be treated as unconfirmed from this record alone.",
"topics": [
"Private Placement",
"Biotechnology",
"Corporation"
],
"summary": "Ansa Biotechnologies, Inc. is a corporation based in Emeryville, California, and filed a Form D for a cash raise with a total offering amount of $71,903,290. The filing reports $54,403,290 sold to 18 investors and lists Jason Gammack and Daniel Lin-Arlow as executive officers/directors, with Yanniv Dorone, Brad Crutchfield, and Nate Cornell as directors.",
"website": "https://ansabio.com",
"location": "EMERYVILLE, CALIFORNIA",
"file_date": "2026-11-18",
"form_type": "D",
"relevance": 0.6,
"confidence": "high",
"exemptions": [
"06b"
],
"filing_url": "https://www.sec.gov/Archives/edgar/data/1816722/000123191926001596/",
"source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001816722&type=D&dateb=&owner=include&count=40",
"entity_name": "Ansa Biotechnologies, Inc.",
"entity_type": "Corporation",
"jurisdiction": "DELAWARE",
"primary_topic": "Biotechnology",
"revenue_range": "Decline to Disclose",
"business_state": "CA",
"industry_group": "Biotechnology",
"related_persons": [
{
"name": "Jason Gammack",
"email": "j***@ansabio.com",
"roles": [
"Executive Officer",
"Director"
],
"linkedin_url": "https://www.linkedin.com/in/jasontgammack"
},
{
"name": "Daniel Lin-Arlow",
"roles": [
"Executive Officer",
"Director"
]
},
{
"name": "Yanniv Dorone",
"roles": [
"Director"
]
},
{
"name": "Brad Crutchfield",
"roles": [
"Director"
]
},
{
"name": "Nate Cornell",
"roles": [
"Director"
]
},
{
"name": "Nick Naclerio",
"roles": [
"Director"
]
},
{
"name": "Chenny Zhang",
"roles": [
"Director"
]
},
{
"name": "Matthias Arenskotter",
"roles": [
"Executive Officer"
]
}
],
"total_investors": 18,
"total_remaining": 17500000,
"accession_number": "0001231919-26-001596",
"securities_types": [
"Equity"
],
"business_location": "Emeryville, CA",
"total_amount_sold": 54403290,
"resolved_entity_name": "Ansa Biotechnologies",
"resolved_entity_type": "operating_company",
"total_offering_amount": 71903290,
"company_domain_confidence": 10,
"has_non_accredited_investors": false
}
}
curl https://signals.autobound.ai/v1/signals/fd-0001231919-26-001596 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"ansabio.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.